Session: 199. HIV 4: Treatment -Outcomes, Adherence, and Toxicities Saturday, October 11, 2014: 12:30 PM Background. Virologic monitoring for HIV-infected ART patients is largely unavailable in resource-limited settings. Undetected viremia may contribute to transmission and breed resistance. Treatment failure may be more common among patients who are not monitored for extended periods. We explored the prevalence of ART failure among previously unmonitored ART patients in Malawi.
Background. Virologic monitoring for HIV-infected ART patients is largely unavailable in resource-limited settings. Undetected viremia may contribute to transmission and breed resistance. Treatment failure may be more common among patients who are not monitored for extended periods. We explored the prevalence of ART failure among previously unmonitored ART patients in Malawi.
Methods. Participants were enrolled from 5 hospitals and were eligible if they were ≥18 and had been on ART for 6 or 24 months or any 2-year period thereafter or if provider suspected failure. Virologic testing was done on dried blood spot cards using Abbott Real-Time HIV-1 Assay. Summary statistics were compared using independent group t-tests (continuous variables) and Pearson's χ2 tests (categorical variables). We used logistic regression to investigate the association between ART history, patient demographics, and virologic failure (viral load >5,000 cp/ml).
Results. Conclusion. We observed an unexpectedly low prevalence of virologic failure among previously unmonitored patients. After controlling for factors that could contribute to treatment failure, younger patients and patients on ART >4 years were more likely to be failing. These results may suggest deficiency in adolescent adherence and adult ART care transitions. Despite being retained in care, our findings demonstrate the importance of virologic monitoring among patients on ART for extended periods, regardless of clinical symptoms.
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